IP Verse

Further Novel Forms Of Interfering Rna Molecules - EP1857547

PATENT ANALYSIS

Patent Details

Grant Date
Dec 2, 2020
Company
ATUGEN AG
Oppositions

ALNYLAM PHARMACEUTICALS, INC.

SANOFI

THE MEDICINES COMPANY UK LIMITED

More patents of Atugen Ag

EP1857547

Want to monitor this patent?

Feel free to send us a message here and we will get back to you